Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eyegaze, formerly known as LC Technologies, is a private U.S. medical technology company focused on eye-tracking and eye-controlled communication systems. The company is best known for the Eyegaze Edge, a commercial assistive communication device that enables people with severe motor and speech impairments to communicate, browse the web, send email, and control applications using eye movement alone. In addition to augmentative and alternative communication products, the company has offered eye-tracking systems, APIs, and research services for human factors, usability, and cognition studies. Eyegaze appears to operate as a commercially active assistive-healthcare and eye-tracking technology company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eyegaze.